Skip to main content

Table 1 Anthropometrical and clinical characteristics of study population

From: Biochemical but not imaging parameters are predictive of outcome in septic shock: a pilot study

Variables All subjects (n = 35)
Age (y) 59 (48; 60)
Gender (M) 21 (60%)
BMI (kg/m2) 25 (22; 29)
Risk Factors
 Smoking habit, n (%) 11 (31%)
 Hypertension, n (%) 18 (51%)
 Dyslipidemia, n (%) 10 (29%)
 Diabetes, n (%) 10 (29%)
 Previous cardiovascular disease, n (%) 5 (14%)
Predisposing factors
 Gastrointestinal diseases, n (%) 10 (29%)
 Autoimmune diseases, n (%) 1 (3%)
 Respiratory diseases, n (%) 7 (20%)
 Vascular surgery/limb iscaemia, n (%) 1 (3%)
 Genitourinary diseases, n (%) 5 (14%)
 Orthopedic/skeletal diseases, n (%) 1 (3%)
 Haematological diseases, n (%) 10 (29%)
Within 30 days mortality, n (%) 15 (43%)
SBP (mmHg) 120 (108; 134)
DBP (mmHg) 60 (55; 65)
MAP (mmHg) 80 (73; 86)
HR (beats/min) 96 (87; 116)
Epinephrine (ɣ/kg/min) 0.09 (0.04; 0.26)
Norepinephrine (ɣ/kg/min) 0.26 (0.12; 0.49)
TnT (ng/L) 91 (38; 193)
PCT (ng/mL) 34 (9; 100)
NT-ProBNP (ng/L) 12,324 (3135; 29,571)
Echocardiograghy values
 VTD (mL) 101 (62; 110)
 VTS (mL) 39 (31; 53)
 Dtd (mm) 45 (41; 51)
 EF (%) 55 (40; 60)
  1. Data are expressed as median and interquartile range (I-III) or as number and percentage. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, HR heart rate, TnT troponine T, PCT pro-calcitonin, NT-ProBNP pro b-type natriuretic peptide, VTD and VTS telediastolic and telesystolic volumes, EF ejection fraction